CorMedix Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $163.1M | $-17.9M | $-46.3M | $-29.7M | $-28.2M | $-22.0M | $-16.4M | $-26.8M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $677.0K | $154.0K | $70.8K | $84.6K | $61.9K | $128.0K | $73.3K | $74.2K |
| Amortization | $13.9M | $156.0K | — | — | — | — | — | — |
| Stock-Based Compensation | $13.8M | $6.1M | $5.5M | $4.1M | $5.0M | $2.5M | $2.4M | $1.1M |
| Net Cash from Operating Activities | $175.0M | $-50.6M | $-38.4M | $-24.4M | $-21.2M | $-22.0M | $-15.1M | $-23.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $2.3M | $116.0K | $327.3K | $219.4K | $1.4M | $112.6K | $36.6K | $48.9K |
| Business Acquisitions | $308.5M | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-308.4M | $21.2M | $-17.1M | $-3.7M | $-9.1M | $7.4M | $-12.0M | $1.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $238.5M | $26.3M | $55.9M | $17.9M | $41.8M | $40.1M | $25.8M | $29.4M |
| Net Change in Cash | $105.1M | $-3.1M | $448.4K | $-10.2M | $11.5M | $25.6M | $-1.3M | $7.2M |
| Free Cash Flow | $172.8M | $-50.7M | $-38.7M | $-24.6M | $-22.6M | $-22.1M | $-15.1M | $-23.7M |